n The World Health Organization (WHO) said millions of doses of experimental Ebola vaccines will be produced by the end of 2015, as they speed up the process of vaccine development to deal with the largest epidemic of the disease in history.
n It normally takes years to produce and test a vaccine, but drug manufacturers are now working on a scale of weeks, as governments and corporations are shifting millions of dollars to fight Ebola in the wake of the outbreak that has infected more than 10,000 people and killed over 4,800.
n Vaccines could be offered to health workers on the frontline in West Africa as soon as December 2014. However, WHO cautioned that vaccines would not be a "magic bullet" for ending the outbreak.
n Experts say international groups and wealthier governments like the United States could buy Ebola vaccines and drugs in mass quantities to stockpile them for future use once they are deemed safe.
n Currently, there is no licensed vaccine for the Ebola virus, however, several experimental ones, including ZMapp, have been tested during this recent outbreak. Recovery from Ebola mainly depends on good supportive care and the patient's immune response.